Piramal Enterprises has raised funds worth Rs 81.24 crore. The Administrative Committee of the Board of Directors of the company at its meeting held on September 25, 2018 approved the allotment of 3,02,000 Equity shares of face value of Rs 2 each at a conversion premium of Rs 2,688 per share pursuant to optional conversion of 7,550 Compulsorily Convertible Debentures (CCDs) of face value of Rs 1,07,600 each aggregating to Rs 81,23,80,000. These Equity shares are proposed to be listed on BSE and National Stock Exchange of India.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
